Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers

NARecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Leishmaniasis
Interventions
DIAGNOSTIC_TEST

In-house Western blot, specific for Leishmania

"Sample will be collected at the collaborating centres and at the DITM, if not already stored at -80°C. The samples will be delivered to the DITM. For the CONTROL groups, two serological tests for Leishmaniasis, based on different antigenic fraction, will be performed on serum samples.~Different strains of Leishmania infantum and Leishmania donovani will be cultivated axenically at the DITM.~Whole soluble fraction of promastigote (WSF), the whole membrane protein fraction (WMF) and the whole soluble fraction secreted by promastigotes (WSFe) of Leishmania spp. will be obtained and the ARPs from WSF, WMF and WSFe, of each Leishmania will be checked trough Western-blot analysis testing at a final dilution of 1/100 each serum sample. The predominant bands detected by Western-blot analysis will be identified by SDS-PAGE separation. Selected bands, corresponding to the immunogenic bands, will be excised, digested and identified with Mass Spectrometry analysis."

Trial Locations (1)

37024

RECRUITING

IRCCS Sacro Cuore Don Calabria hospital, Negrar

All Listed Sponsors
lead

IRCCS Sacro Cuore Don Calabria di Negrar

OTHER